PGI29 AN ECONOMIC EVALUATION OF TOFACITINIB IN THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE UNITED KINGDOM
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1151
https://www.valueinhealthjournal.com/article/S1098-3015(19)33529-6/fulltext
Title :
PGI29 AN ECONOMIC EVALUATION OF TOFACITINIB IN THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE UNITED KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33529-6&doi=10.1016/j.jval.2019.09.1151
First page :
Section Title :
Open access? :
No
Section Order :
11007